Inside The TRIAD Trial
31:10–32:20 · 71s
Bryn details the stringent, double-blind, placebo-controlled design, inclusion criteria, and three-year timeline tracking real outcomes in aging dogs.
31:10–32:20 · 71s
Bryn details the stringent, double-blind, placebo-controlled design, inclusion criteria, and three-year timeline tracking real outcomes in aging dogs.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.